Drug-induced dysphonia

Close metadata

Recommended articles:

Voice disorders associated with novel coronavirus infection. Russian Bulletin of Otorhinolaryngology. 2023;(6):30-37

Application of the biofeedback method in the treatment of dysphonia (literature review). Russian Bulletin of Otorhinolaryngology. 2023;(6):67-72

Efficacy of prevention of recurrent laryngeal nerve injury in thyroid surgery. Pirogov Russian Journal of Surgery. 2024;(7):85-91

Drug-induced dysphonia is a non-life-threatening adverse drug reaction, however, this complication can significantly worsen the quality of life of patients, especially those in voice-speaking professions. The aim of the work was to search for information about the prevalence, etiology, pathogenesis, and features of treatment and prevention of drug-induced dysphonia. In the case of some drugs, the true prevalence may be higher than described in the literature, due to the fact that dysphonia is in most cases mild, reversible and, in comparison with other undesirable drug reactions, rarely attracts the attention of both the patient and practitioners.

Keywords:

dysphonia

drug-induced dysphonia

adverse drug reaction

Authors:

Ostroumova O.D.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 3910-6585
Scopus AuthorID: 7004067629
ResearcherID: M-9553-2014
ORCID: 0000-0002-0795-8225

Shikh E.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-6589-7654

Svistushkin V.M.

Sechenov First Moscow State Medical University

ORCID: 0000-0002-1257-9879

Rebrova E.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Ryazanova A.Y.

Volgograd State Medical University

Rakunova E.B.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia

Received:

17.02.2019

Accepted:

21.05.2020

List of references:

Cohen SM, Kim J, Roy N, Asche C, Courey M. Prevalence and causes of dysphonia in a large treatment-seeking population. Laryngoscope. 2012;122(2):343-348. https://doi.org/10.1002/lary.22426
https://www.drugs.com
Drug-induced vocal cord disorders. Prescrire Int. 2018;27(189):13-17.
Chmielewska M, Akst LM. Dysphonia associated with the use of inhaled corticosteroids. Current Opinion in Otolaryngology & Head and Neck Surgery. 2015;23(3):255-259. https://doi.org/10.1097/MOO.0000000000000153
Yalcin O, Aslan AA, Sari BA, Turkbay T. Possible Methylphenidate Related Hoarseness and Disturbances of Voice Quality: Two Pediatric Cases. Bulletin of Clinical Psychopharmacology. 2012;22(3):278-282. https://doi.org/10.5455/bcp.20120731061626
Galván CA, Guarderas JC. Practical Considerations for Dysphonia Caused by Inhaled Corticosteroids. Mayo Clin Proc. 2012;87(9):901-904. https://doi.org/10.1016/j.mayocp.2012.06.022
Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006;290:560-576. https://doi.org/10.1152/ajpheart.00133.2005
Vazquez FJ. Dysphonia Secondary to Perindopril Treatment. AJH. 2003;16:329-330. https://doi.org/10.1016/S0895-7061(03)00005-0
Schwartz SR, Cohen SM, Dailey SH, Rosenfeld RM, Deutsch ES, Gillespie MB, et al. Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg. 2009;141(2):1-31. https://doi.org/10.1016/j.otohns.2009.06.744
Rasimas JJ, Liebelt EL. Adverse Effects and Toxicity of the Atypical Antipsychotics: What is Important for the Pediatric Emergency Medicine Practitioner. Clin Pediatr Emerg Med. 2012;13(4):300-310. https://doi.org/10.1016/j.cpem.2012.09.005
Tsai CS, Lee Y, Chang YY, Lin PY. Ziprasidone-induced tardive laryngeal dystonia: a case report. Gen Hosp Psychiatry. 2008;30(3):277-279. https://doi.org/10.1016/j.genhosppsych.2007.08.012.
Collins N, Sager J. Acute laryngeal dystonia: drug-induced respiratory failure related to antipsychotic medications. J Neurol Neuromedicine. 2018;3(1):4-7. https://doi.org/10.29245/2572.942X/2017/1.1167
Wardle PG, Whitehead MI, Mills RP. Non-reversible and wide ranging voice changes after treatment with danazol. Br Med J (Clin Res Ed). 1983;287(6397):946. https://doi.org/10.1136/bmj.287.6397.946
Buttram VC, Belue JB, Reiter R. Interim report of a study of danazol for the treatment of endometriosis. Fertil Steril. 1982;37:478-483. https://doi.org/10.1016/s0015-0282(16)46151-0
Tisdale JE, Miller DA. Drug Induced Diseases: Prevention, Detection, and Management. 3rd Ed. Bethesda, Md.: American Society of Health-System Pharmacists. 2018;1399.
Stachler RJ, Francis DO, Schwartz SR, Damask CC, Digoy GP, Krouse HJ, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) Executive Summary. Otolaryngol Head Neck Surg. 2018;158(3):409-426. https://doi.org/10.1177/0194599817751031
Haft S, Farquhar D, Carey R, Mirza N. Anticholinergic use is a major risk factor for dysphonia. Ann Otol Rhinol Laryngol. 2015;124(10):797-802. https://doi.org/10.1177/0003489415585867
Antón-Aparicio L, Cassinello J, Caneda MCL. Elucidating the biophysic mechanims of axitinib-induced dysphonia. Journal of Clinical Oncology. 2015;33(15):15607-15607. https://doi.org/10.1200/jco.2015.33.15_suppl.e15607
Saavedra E, Hollebecque A, Soria JC, Hartl DM. Dysphonia induced by anti-angiogenic compounds. Invest New Drugs. 2014;32:774-782. https://doi.org/10.1007/s10637-013-0049-2
Caruso AM, Meyer TK, Allen CT. Hoarseness after metastatic colon cancer treatment. JAMA Otolaryngol Head Neck Surg. 2014;140:881-882. https://doi.org/10.1001/jamaoto.2014.1766
Reiter R, Hoffmann TK, Pickhard A, Brosch S. Hoarseness — Causes and Treatments. Dtsch Arztebl Int. 2015;112(19):329-237. https://doi.org/10.3238/arztebl.2015.0329
Otorhinolaryngology. National leadership. Brief Edition. Pod red. V.T. Pal’chuna. M.: GEOTAR-Media; 2014. (In Russ.).
Hakkesteegt MM, Brocaar MP, Wieringa HH. The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery. J Voice. 2010;24(2):199-205. https://doi.org/10.1016/j.jvoice.2008.06.007.
Nawka T, Verdonck-de Leeuw IM, De Bodt M, Guimaraes I, Holmberg EB, Rosen CA, Schindler A, Woisard V, Whurr R, Konerding U. Item reduction of the voice handicap index based on the original version and on European translations. Folia Phoniatr Logop. 2009;61(1):37-48. https://doi.org/10.1159/000200767.
Uloza V, Saferis V, Uloziene I. Perceptual and acoustic assessment of voice pathology and the efficiacy of endolaryngeal phonomicrosurgery. J Voice. 2005;19:138-145.
Shilenkova VV. Acoustic Voice Analysis. Monograph. Yaroslavl: Obverse Plus; 2015. (In Russ.).
Shilenkova VV. Dysphonies and voice. Yaroslavl: Obverse plus; 2018. (In Russ.).
Sizov AG, Meshcheryakov RV, Tiunov SD. Assessment of the voice quality of persons with dysphonia. Trudy SPIIRAN. 2012;1(20):138-152. (In Russ.).
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. https://doi.org/10.1038/clpt.1981.154
Williams MLT, Kane C, Shim CS. Treatment of asthma with triamcinolone acetonide delivered by aerosol. Am Rev Respir Dis. 1974;109(5):538-543. https://doi.org/10.1164/arrd.1974.109.5.538
British Thoracic and Tuberculosis Association. A controlled trial of inhaled corticosteroids in patients receiving Prednisone tablets for asthma. Br J Dis Chest. 1976;70(2):95-103. https://doi.org/10.1016/0007-0971(76)90013-9
Willey RF, Milne LJR, Crompton GK, Grant IWB. Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. British Journal of Diseases of the Chest. 1976;70:32-38. https://doi.org/10.1016/0007-0971(76)90004-8
Kass I, Vijayachandra NS, Patil KD. Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthmatic patients. An assessment of 18 months of therapy. Chest. 1977;71(6):703-707. https://doi.org/10.1378/chest.71.6.703
Lindgren S, Eriksson NE, Lindholm N. Experience of local inhalation of beclomethasone dipropionate (becotide) in the treatment of adult steroid-dependent asthmatic patients. Stand J Respir Dis. 1977;101:163.
Toogood JH, Jennings B, Greenway RW, Chuang L Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol. 1980;65(2):145-153. https://doi.org/10.1016/0091-6749(80)90200-6
Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 1983;38(11):813-821. https://doi.org/10.1136/thx.38.11.813
Dong JC, Shen ZY, Wang WJ. The investigation on 100 bronchial asthma and asthmatic bronchitis cases treated with high dose beclomethasone dipropionate aerosol [in Chinese]. Zonghua Jie He He Hu Xi Za Zhi. 1993;16(1):33-35.
Williamson IJ, Matusiewicz SP, Brown PH, Greening AP, Crompton GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J. 1995;8(4):590-592.
Bhalla RK, Taylor W, Jones AS, Roland NJ. The inflammation produced by corticosteroid inhalers in the pharynx in asthmatics. Clin Otolaryngol. 2008;33(6):581-586. https://doi.org/10.1111/j.1749-4486.2008.01837.x.
Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid—induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol. 2007;98(3):225-238. https://doi.org/10.1016/S1081-1206(10)60711-9
Selroos O, Backman R, Forsén KO, Löfroos AB, Niemistö M, Pietinalho A, et al. Local side-effects during 4-year treatment with inhaled corticosteroids: a comparison between pressurized metered-dose inhalers and Turbuhaler. Allergy. 1994;49(10):888-890. https://doi.org/10.1111/j.1398-9995.1994.tb00794.x
Andrejak M, Andrejak MT, Osterman G. Enalapril, captopril and cough. Arch Intern Med. 1988;148:249.
Karpman L. Cough from ACE inhibitors. Am Heart J. 1988;116:1958.
McEwan JR, Choundry N, Street R, Fuller RW. Change in cough reflex after treatment with enalapril and ramipril. Br Med J. 1989;299:13-16. https://doi.org/10.1136/bmj.299.6690.13
Erdos EG. Some old and new ideas on kinin metabolism. J Cardio-vasc Pharmacol. 1990;15(6):20-24.
Tenenbaum A, Grossman E, Schemesh J, Fisman E, Nasrati I, Motro M. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens. 2000;13:776-782. https://doi.org/10.1016/s0895-7061(00)00268-5
Joubert P. Side Effects of Drugs Annual. Side Effects of Drugs Annual. 2005;28:226-232.
Fuchs M, Bücheler M. Chronic hyperplastic laryngitis following treatment of hypertension with angiotensin converting enzyme-inhibitor. HNO. 2004;52(11):998-1000. https://doi.org/10.1007/s00106-003-1016-6
Carter CA, Caroen SZ, Oronsky AL, Oronsky BT. Dysphonia after Bevacizumab Rechallenge: A Case Report. Case Rep Oncol. 2015;8:423-425. https://doi.org/10.1159/000441122
Weiser GA, Forouhar FA, White WB, Hydralazine Hoarseness A New Appearance of Drug-Induced Systemic Lupus Erythematosus. Arch Intern Med. 1984;144(11):2271-2272. https://doi.org/10.1001/archinte.1984.04400020199034
Brosch S, Johannsen HS. Medication-induced vocal cord paralysis as an uncommon cause of cord paralysis. HNO. 1999;47(9):825-827. https://doi.org/10.1007/s001060050467
Bhutta MF, Rance M, Gillett D, Weighill JS. Alendronate-induced chemical laryngitis. The Journal of Laryngology & Otology. 2005;119(1):46-47. https://doi.org/10.1258/0022215053222969
Singh V, Cohen SM, Rousseau B, Noordzij JP, Garrett CG, Ossoff RH. Acute dysphonia secondary to vocal fold hemorrhage after vardenafil use. Ear Nose Throat J. 2010;89(6):21-22.
American Academy of Otolaryngology-Head and Neck Surgery. Clinical Practice Guideline: Hoarseness (Dysphonia). https://www.entnet.org/content/clinical-practice-guideline-hoarseness-dysphonia. Published June 24, 2019.
Beglyarov ME. The method of voice restoration in functional dysphonias in persons with voice-speaking professions. Vestnik otorinolaringologii. 2005;5:50-51. (In Russ.).
Stepanova YuYe, Makhotkina NN. Principles of the syndromopathogenetic approach to the appointment of physiotherapy in patients with dysphonia (review). Rossiyskaya otorinolaringologiya. 2013;5(66):126-129. (In Russ.).

Close metadata